Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Author's Reply to Pongpirul: "The Pharmaceutical Year that was, 2024".
Pharmaceut Med
December 2024
Pharmaceutical Medicine, London, UK.
'Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates' - Author's reply.
Clin Microbiol Infect
December 2024
Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland. Electronic address:
Author's Reply to Peronard and Mayntz: "SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect".
Am J Cardiovasc Drugs
December 2024
Internal Medicine Research Group, Universidad Libre, Cali, Colombia.
The potential impact of educational attainment on NAFLD risk. Author's reply.
Eur J Intern Med
December 2024
First Department of Medicine, University Clinic Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria; Institute of General Practice, Family Medicine and Preventive Medicine, Paracelsus Medical University of Salzburg, Salzburg, Austria; Department of Internal Medicine, Saint John of God Hospital, Teaching Hospital of the Paracelsus Medical Private University, Salzburg, Austria. Electronic address:
Author's reply: "Impact of graft-to-recipient weight ratio on early systemic inflammatory response syndrome risk following pediatric liver transplantation".
Dig Liver Dis
December 2024
Department of Organ Transplantation Center, First Affiliated Hospital of Guangxi Medical University, Guangxi, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!